Evidence map›Paper›PMID 25972494›Full record

ArticleNeurology2015

Screening with MRI for Accurate and Rapid Stroke Treatment: SMART.

Shreyansh Shah, Marie Luby, Karen Poole, Teresa Morella, Elizabeth Keller, Richard T Benson, John K Lynch, Zurab Nadareishvili, Amie W Hsia

Open access · bronzeAbstract read
In one paragraph

Article in Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Brain imaging with portable low-field MRI.Nature reviews bioengineering · 2023
    Article
  9. Article
  10. Article
  11. Retinal and optic nerve magnetic resonance diffusion-weighted imaging in acute non-arteritic central retinal artery occlusion.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2022
    Article
  12. Observational
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Routine use of FLAIR-negative MRI in the treatment of unknown onset stroke.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2020
    Article
  19. Biomarker Application for Precision Medicine in Stroke.Translational stroke research · 2020
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shreyansh ShahFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Marie LubyFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Karen PooleFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Teresa MorellaFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Elizabeth KellerFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Richard T BensonFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
John K LynchFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Zurab NadareishviliFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD.
Amie W HsiaFrom the Section on Stroke Diagnostics and Therapeutics (S.S., M.L., K.P., T.M., R.T.B., J.K.L., Z.N., A.W.H.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; MedStar Washington Hospital Center Stroke Center (K.P., E.K., R.T.B., A.W.H.), Washington, DC; and Suburban Hospital Stroke Program (T.M., Z.N.), Bethesda, MD. amie.hsia@medstar.net.
MedStar Washington Hospital Center · US

Funding

CLINICAL AND IMAGING CORE SUPPORT OF ACUTE STROKE RESEARCHZICNS003044 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI LATOUR, LAWRENCE · 2015 to 2025
$32.8M
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANSZIANS003043 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI LATOUR, LAWRENCE · 2009 to 2025
$19.5M
Intramural NIH HHS
6 · The paper itself

Abstract

objectiveThe objective of this study was to demonstrate the feasibility of timely multimodal MRI screening before thrombolysis in acute stroke patients.

methodsQuality improvement processes were initiated in 2013 to reduce door-to-needle (DTN) time at the 2 hospitals where the NIH stroke team provides clinical care. Acute ischemic stroke (AIS) patients who received IV tissue plasminogen activator (tPA) ≤4.5 hours from last known normal were identified. Demographic and clinical characteristics and timing metrics were analyzed comparing the time periods before, during, and after the quality improvement processes.

resultsThere were 157 patients treated with IV tPA for AIS during 2012-2013, of whom 135 (86%) were screened with MRI. DTN time was significantly reduced by 40% during this period from a median of 93 minutes in the first half of 2012 to 55 minutes in the last half of 2013 (p < 0.0001) with a significant 4-fold increase in the proportion of treated patients with DTN time ≤60 minutes from 13.0% to 61.5%, respectively (p < 0.00001). Improvement in DTN time was associated with reduced door-to-MRI time, and there were no differences in demographic or clinical characteristics (p = 0.21-0.76).

conclusionsIt is feasible and practical to consistently and rapidly deliver IV tPA to AIS patients within national benchmark times using MRI as the routine screening modality. The processes used in the SMART (Screening with MRI for Accurate and Rapid Stroke Treatment) Study to reduce DTN time have the potential to be widely applicable to other hospitals.

Indexed as

Acute DiseaseAdministration, IntravenousAgedAged, 80 and overBrainBrain IschemiaFeasibility StudiesFemaleFibrinolytic AgentsHumansMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingQuality ImprovementStrokeFibrinolytic AgentsTissue Plasminogen Activator

Identifiers

PMID25972494
PMCPMC4478034
OpenAlexW1688941701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.